Latest Transformation News

Klevo Rewards partners with Bybit to launch KLVAUD, an Australian dollar-backed stablecoin integrated with a Mastercard and a global rewards ecosystem. This move aims to transform everyday spending into digital asset rewards accessible worldwide.

Stakk Limited’s U.S. subsidiary has landed its largest-ever contract worth A$7.85 million, marking a significant step in expanding its AI-native trust infrastructure across regulated industries including healthcare.

BlinkLab has enrolled its first participant in the pivotal FDA 510(k) validation study for its autism diagnostic aid, BlinkLab Dx1, aiming for regulatory submission by the end of 2026.

dorsaVi has commenced development of Sensor V6.5, a firmware upgrade that embeds intelligence directly within its wearable sensors, reducing latency and paving the way for future neuromorphic computing integration.

Emmerson Resources has invoiced $10.53 million from its joint venture partner as part of a minimum production payment, coinciding with its pending $311 million acquisition by Pan African Resources.

Killi Resources has appointed former Fortescue CEO Nev Power as Non-Executive Chair and secured $1.4 million through a share placement led by Power and other key executives. The capital will support exploration at Mt Rawdon West and new growth initiatives.

Caprice Resources has kicked off an ambitious 50,000-metre drilling campaign across its Murchison Gold Projects, aiming to define a maiden Mineral Resource Estimate and uncover new high-grade gold zones.

BlinkLab’s smartphone-based Dx1 autism screening technology has been selected for Morocco’s government-funded national early screening program, marking a major milestone in digital health adoption and autism care.

Tolu Minerals has locked in a significant A$23.75 million investment from Indonesian heavyweights Petrindo and Petrosea, setting the stage for a major infrastructure push at the Tolukuma Gold Mine ahead of planned production in early 2027.

Green360 Technologies has inked a binding toll treatment agreement with Calix Limited to commercially produce Eco-Clay, a low-carbon cement replacement, marking a key step toward scaling sustainable concrete solutions in Australia.

Cyclopharm has secured a significant multi-site agreement with the University of Pennsylvania Health System, marking a major step in its US expansion with installations across 11 clinical locations.

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.